Magen et al. discovered new miRNA-based biomarkers in the blood of patients with ALS. miR-181 levels alone or in combination with an established protein biomarker predict ALS severity and prognosis and might enhance the power of clinical trials.
- Iddo Magen
- Nancy Sarah Yacovzada
- Eran Hornstein
